{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:38:34Z","timestamp":1786358314040,"version":"build-2736575974"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T00:00:00Z","timestamp":1581897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["PO1AG014449"],"award-info":[{"award-number":["PO1AG014449"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG043375"],"award-info":[{"award-number":["R01AG043375"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG019610"],"award-info":[{"award-number":["P30AG019610"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Chitinase 3-like 1 (CHI3L1), chitinase 3-like 2 (CHI3L2), and neuronal pentraxin II (NPTX2) are inflammatory biomarkers of Alzheimer\u2019s disease (AD). Although studies have demonstrated that cerebrospinal fluid levels of these proteins are changed in AD, no studies have undertaken a detailed examination of alterations in protein levels, cellular expression, and interaction with amyloid in the brain during the progression of AD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study evaluated levels of both CHI3L1 and CHI3L2, NPTX2, ionized calcium-binding adapter molecule 1 (Iba1), complement component 1q (C1q), glial fibrillary acidic protein (GFAP), and CD44, in the frontal cortex of people who died with an antemortem clinical diagnosis of no\u00a0cognitive impairment (NCI), mild cognitive impairment (MCI), mild\/moderate AD (mAD), and severe AD (sAD) using immunoblot and immunohistochemical techniques.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CHI3L1-immunoreactive (-ir) astrocyte numbers were increased in the frontal cortex and white matter in sAD compared to NCI. On the other hand, increases in GFAP and Iba1-ir cell numbers were observed in MCI compared to NCI but only in white matter. Western blot analyses revealed significantly lower frontal cortex CHI3L2 levels, whereas CD44 levels were increased in sAD. No significant differences for CHI3L1, GFAP, C1q, and NPTX2 protein levels were detected between clinical groups. Strong significant correlations were found between frontal cortex CHI3L1 and Iba1-ir cell numbers in white matter and CHI3L1 and C1q protein levels in the early stages of the disease. C1q and Iba1, CD44 with CHI3L2, and GFAP protein levels were associated during disease progression. CHI3L1 and Iba1 cell numbers in white matter showed a\u00a0significant associations with episodic memory and perceptual speed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>White matter CHI3L1 inflammatory response is associated with cognitive impairment early in the onset of AD.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12974-020-1723-x","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T12:04:57Z","timestamp":1581941097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Marta","family":"Moreno-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Malek-Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4438-7334","authenticated-orcid":false,"given":"Elliott J.","family":"Mufson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,17]]},"reference":[{"key":"1723_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","volume":"12","author":"Alzheimer\u2019s Association","year":"2016","unstructured":"Alzheimer\u2019s Association. 2016 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2016;12:459\u2013509.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1723_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","volume":"13","author":"A Wimo","year":"2017","unstructured":"Wimo A, Guerchet M, Ali GC, Wu YT, Prina AM, Winblad B, Jonsson L, Liu Z, Prince M. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimer\u2019s Dement. 2017;13:1\u20137.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1723_CR3","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/archneur.58.9.1403","volume":"58","author":"DH Salat","year":"2001","unstructured":"Salat DH, Kaye JA, Janowsky JS. Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Arch Neurol. 2001;58:1403\u20138.","journal-title":"Arch Neurol"},{"key":"1723_CR4","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1523\/JNEUROSCI.5062-08.2009","volume":"29","author":"RL Buckner","year":"2009","unstructured":"Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer\u2019s disease. J Neurosci. 2009;29:1860\u201373.","journal-title":"J Neurosci"},{"key":"1723_CR5","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA. Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25:7709\u201317.","journal-title":"J Neurosci"},{"key":"1723_CR6","first-page":"10","volume":"20","author":"S Andrade","year":"2019","unstructured":"Andrade S, Ramalho MJ, Loureiro JA, Pereira MDC. Natural compounds for Alzheimer\u2019s disease therapy: a systematic review of preclinical and clinical studies. Int J Mol Sci. 2019;20:10.","journal-title":"Int J Mol Sci"},{"key":"1723_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","volume":"705","author":"NN Naseri","year":"2019","unstructured":"Naseri NN, Wang H, Guo J, Sharma M, Luo W. The complexity of tau in Alzheimer\u2019s disease. Neurosci Lett. 2019;705:183\u201394.","journal-title":"Neurosci Lett"},{"key":"1723_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer\u2019s disease. Neurobiol Aging. 2000;21:383\u2013421.","journal-title":"Neurobiol Aging"},{"key":"1723_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/jnr.490390406","volume":"39","author":"JG Sheng","year":"1994","unstructured":"Sheng JG, Mrak RE, Griffin WS. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. J Neurosci Res. 1994;39:398\u2013404.","journal-title":"J Neurosci Res"},{"key":"1723_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10787-019-00580-x","volume":"27","author":"D Kaur","year":"2019","unstructured":"Kaur D, Sharma V, Deshmukh R. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease. Inflammopharmacology. 2019;27:663\u201377.","journal-title":"Inflammopharmacology."},{"key":"1723_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12877-018-0949-2","volume":"18","author":"N Boublay","year":"2018","unstructured":"Boublay N, Federico D, Pesce A, Verny M, Blanc F, Paccalin M, Desmidt T, Grosmaitre P, Moreaud O, Relland S, Bravant E, Bouet R, Krolak-Salmon P. Study protocol on Alzheimer\u2019s disease and related disorders: focus on clinical and imaging predictive markers in co-existing lesions. BMC Geriatr. 2018;18:280.","journal-title":"BMC Geriatr"},{"key":"1723_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0361-9230(03)00088-1","volume":"61","author":"E Tarkowski","year":"2003","unstructured":"Tarkowski E, Liljeroth AM, Minthon L, Tarkowski A, Wallin A, Blennow K. Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res Bull. 2003;61:255\u201360.","journal-title":"Brain Res Bull"},{"key":"1723_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/archpedi.1995.02170180089017","volume":"149","author":"MR Griffin","year":"1995","unstructured":"Griffin MR, Daugherty J, Reed GW, Standaert SM, Hutchins SS, Hutcheson RH, Schaffner W. Immunization coverage among infants enrolled in the Tennessee Medicaid program. Arch Pediatr Adolesc Med. 1995;149:559\u201364.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1723_CR14","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","volume":"86","author":"WS Griffin","year":"1989","unstructured":"Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A. 1989;86:7611\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1723_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neurobiolaging.2017.02.012","volume":"54","author":"SE Perez","year":"2017","unstructured":"Perez SE, Nadeem M, He B, Miguel JC, Malek-Ahmadi MH, Chen K, Mufson EJ. Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer\u2019s disease. Neurobiol Aging. 2017;54:133\u201343.","journal-title":"Neurobiol Aging"},{"key":"1723_CR16","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s10072-015-2274-2","volume":"36","author":"Y Lu","year":"2015","unstructured":"Lu Y, Liu W, Wang X. TREM2 variants and risk of Alzheimer\u2019s disease: a meta-analysis. Neurol Sci. 2015;36:1881\u20138.","journal-title":"Neurol Sci"},{"key":"1723_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2047-9158-2-21","volume":"2","author":"Y Shen","year":"2013","unstructured":"Shen Y, Yang L, Li R. What does complement do in Alzheimer\u2019s disease? Old molecules with new insights. Transl Neurodegener. 2013;2:21.","journal-title":"Transl Neurodegener"},{"key":"1723_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0165-5728(89)90115-X","volume":"24","author":"S Itagaki","year":"1989","unstructured":"Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J.Neuroimmunol. 1989;24:173\u201382.","journal-title":"J.Neuroimmunol"},{"key":"1723_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fnagi.2018.00359","volume":"10","author":"X Zhang","year":"2018","unstructured":"Zhang X, Fu Z, Meng L, He M, Zhang Z. The early events that initiate beta-amyloid aggregation in Alzheimer\u2019s disease. Front Aging Neurosci. 2018;10:359.","journal-title":"Front Aging Neurosci"},{"key":"1723_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fnint.2013.00059","volume":"7","author":"MA Meraz-Rios","year":"2013","unstructured":"Meraz-Rios MA, Toral-Rios D, Franco-Bocanegra D, Villeda-Hernandez J, Campos-Pena V. Inflammatory process in Alzheimer\u2019s disease. Front Integr Neurosci. 2013;7:59.","journal-title":"Front Integr Neurosci"},{"key":"1723_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/JAD-180326","volume":"66","author":"C Lomiguen","year":"2018","unstructured":"Lomiguen C, Vidal L, Kozlowski P, Prancan A, Stern R. Possible role of chitin-like proteins in the etiology of Alzheimer\u2019s disease. J Alzheimers Dis. 2018;66:439\u201344.","journal-title":"J Alzheimers Dis"},{"key":"1723_CR22","doi-asserted-by":"publisher","unstructured":"Xiao MF, Xu D, Craig MT, Pelkey KA, Chien CC, Shi Y, Zhang J, Resnick S, Pletnikova O, Salmon D, Brewer J, Edland S, Wegiel J, Tycko B, Savonenko A, Reeves RH, Troncoso JC, McBain CJ, Galasko D, Worley PF. NPTX2 and cognitive dysfunction in Alzheimer\u2019s disease. Elife. 2017;6. https:\/\/doi.org\/10.7554\/eLife.23798.","DOI":"10.7554\/eLife.23798"},{"key":"1723_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1436922","volume":"7","author":"T Liu","year":"2018","unstructured":"Liu T, Larionova I, Litviakov N, Riabov V, Zavyalova M, Tsyganov M, Buldakov M, Song B, Moganti K, Kazantseva P, Slonimskaya E, Kremmer E, Flatley A, Kluter H, Cherdyntseva N, Kzhyshkowska J. Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy. Oncoimmunology. 2018;7:e1436922.","journal-title":"Oncoimmunology"},{"key":"1723_CR24","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.biopha.2018.02.050","volume":"100","author":"A Pouyafar","year":"2018","unstructured":"Pouyafar A, Heydarabad MZ, Mahboob S, Mokhtarzadeh A, Rahbarghazi R. Angiogenic potential of YKL-40 in the dynamics of tumor niche. Biomed Pharmacother. 2018;100:478\u201385.","journal-title":"Biomed Pharmacother"},{"key":"1723_CR25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/mds.26578","volume":"31","author":"S Hall","year":"2016","unstructured":"Hall S, Surova Y, Ohrfelt A, Swedish BioFINDER Study, Blennow K, Zetterberg H, Hansson O. Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson\u2019s disease. Mov Disord. 2016;31:898\u2013905.","journal-title":"Mov Disord"},{"key":"1723_CR26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1089\/neu.2010.1310","volume":"27","author":"D Bonneh-Barkay","year":"2010","unstructured":"Bonneh-Barkay D, Zagadailov P, Zou H, Niyonkuru C, Figley M, Starkey A, Wang G, Bissel SJ, Wiley CA, Wagner AK. YKL-40 expression in traumatic brain injury: an initial analysis. J Neurotrauma. 2010;27:1215\u201323.","journal-title":"J Neurotrauma"},{"key":"1723_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.virusres.2016.10.012","volume":"227","author":"C Sanfilippo","year":"2017","unstructured":"Sanfilippo C, Nunnari G, Calcagno A, Malaguarnera L, Blennow K, Zetterberg H, Di Rosa M. The chitinases expression is related to simian immunodeficiency virus encephalitis (SIVE) and in HIV encephalitis (HIVE). Virus Res. 2017;227:220\u201330.","journal-title":"Virus Res"},{"key":"1723_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/neup.12158","volume":"35","author":"CA Wiley","year":"2015","unstructured":"Wiley CA, Bonneh-Barkay D, Dixon CE, Lesniak A, Wang G, Bissel SJ, Kochanek PM. Role for mammalian chitinase 3-like protein 1 in traumatic brain injury. Neuropathology. 2015;35:95\u2013106.","journal-title":"Neuropathology"},{"key":"1723_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12974-018-1249-7","volume":"15","author":"I Hakansson","year":"2018","unstructured":"Hakansson I, Tisell A, Cassel P, Blennow K, Zetterberg H, Lundberg P, Dahle C, Vrethem M, Ernerudh J. Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis. J Neuroinflammation. 2018;15:209\u2013018.","journal-title":"J Neuroinflammation"},{"key":"1723_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2353\/ajpath.2008.080045","volume":"173","author":"D Bonneh-Barkay","year":"2008","unstructured":"Bonneh-Barkay D, Bissel SJ, Wang G, Fish KN, Nicholl GC, Darko SW, Medina-Flores R, Murphey-Corb M, Rajakumar PA, Nyaundi J, Mellors JW, Bowser R, Wiley CA. YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am J Pathol. 2008;173:130\u201343.","journal-title":"Am J Pathol"},{"key":"1723_CR31","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/ene.12960","volume":"23","author":"M Mollgaard","year":"2016","unstructured":"Mollgaard M, Degn M, Sellebjerg F, Frederiksen JL, Modvig S. Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis. Eur J Neurol. 2016;23:898\u2013905.","journal-title":"Eur J Neurol"},{"key":"1723_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.msard.2018.05.017","volume":"24","author":"MS Boesen","year":"2018","unstructured":"Boesen MS, Jensen PEH, Magyari M, Born AP, Uldall PV, Blinkenberg M, Sellebjerg F. Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes. Mult Scler Relat Disord. 2018;24:175\u201383.","journal-title":"Mult Scler Relat Disord"},{"key":"1723_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbr.2018.02.015","volume":"347","author":"A Swanson","year":"2018","unstructured":"Swanson A, Wolf T, Sitzmann A, Willette AA. Neuroinflammation in Alzheimer\u2019s disease: pleiotropic roles for cytokines and neuronal pentraxins. Behav Brain Res. 2018;347:49\u201356.","journal-title":"Behav Brain Res"},{"key":"1723_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000496920","volume":"9","author":"JE Park","year":"2019","unstructured":"Park JE, Choi KY, Kim BC, Choi SM, Song MK, Lee JJ, Kim J, Song HC, Kim HW, Ha JM, Seo EH, Song WK, Park SG, Lee JS, Lee KH. Cerebrospinal fluid biomarkers for the diagnosis of prodromal Alzheimer\u2019s disease in amnestic mild cognitive impairment. Dement Geriatr Cogn Dis Extra. 2019;9:100\u201313.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"1723_CR35","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3233\/JAD-170680","volume":"62","author":"M Bjerke","year":"2018","unstructured":"Bjerke M, Engelborghs S. Cerebrospinal fluid biomarkers for early and differential Alzheimer\u2019s disease diagnosis. J Alzheimers Dis. 2018;62:1199\u2013209.","journal-title":"J Alzheimers Dis"},{"key":"1723_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-018-0127-7","volume":"7","author":"H Zhang","year":"2018","unstructured":"Zhang H, Ng KP, Therriault J, Kang MS, Pascoal TA, Rosa-Neto P, Gauthier S, Alzheimer\u2019s Disease Neuroimaging Initiative. Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer\u2019s disease. Transl Neurodegener. 2018;7:23.","journal-title":"Transl Neurodegener"},{"key":"1723_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13195-015-0142-1","volume":"7","author":"MI Kester","year":"2015","unstructured":"Kester MI, Teunissen CE, Sutphen C, Herries EM, Ladenson JH, Xiong C, Scheltens P, van der Flier WM, Morris JC, Holtzman DM, Fagan AM. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer\u2019s disease in a memory clinic cohort. Alzheimers Res Ther. 2015;7:59.","journal-title":"Alzheimers Res Ther"},{"key":"1723_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1742-2094-7-34","volume":"7","author":"D Bonneh-Barkay","year":"2010","unstructured":"Bonneh-Barkay D, Wang G, Starkey A, Hamilton RL, Wiley CA. In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation. 2010;7:34.","journal-title":"J Neuroinflammation"},{"key":"1723_CR39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/9780470035399.ch7","volume":"279","author":"C Garlanda","year":"2006","unstructured":"Garlanda C, Bottazzi B, Salvatori G, De Santis R, Cotena A, Deban L, Maina V, Moalli F, Doni A, Veliz-Rodriguez T, Mantovani A. Pentraxins in innate immunity and inflammation. Novartis Found Symp. 2006;279:80\u20136.","journal-title":"Novartis Found Symp"},{"key":"1723_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","volume":"23","author":"C Garlanda","year":"2005","unstructured":"Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005;23:337\u201366.","journal-title":"Annu Rev Immunol"},{"key":"1723_CR41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0896-6273(03)00463-X","volume":"39","author":"D Xu","year":"2003","unstructured":"Xu D, Hopf C, Reddy R, Cho RW, Guo L, Lanahan A, Petralia RS, Wenthold RJ, O'Brien RJ, Worley P. Narp and NP1 form heterocomplexes that function in developmental and activity-dependent synaptic plasticity. Neuron. 2003;39:513\u201328.","journal-title":"Neuron"},{"key":"1723_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0896-6273(00)80782-5","volume":"23","author":"RJ O'Brien","year":"1999","unstructured":"O'Brien RJ, Xu D, Petralia RS, Steward O, Huganir RL, Worley P. Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product Narp. Neuron. 1999;23:309\u201323.","journal-title":"Neuron"},{"key":"1723_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneuroim.2014.06.016","volume":"274","author":"M Miskimon","year":"2014","unstructured":"Miskimon M, Han S, Lee JJ, Ringkamp M, Wilson MA, Petralia RS, Dong X, Worley PF, Baraban JM, Reti IM. Selective expression of Narp in primary nociceptive neurons: role in microglia\/macrophage activation following nerve injury. J Neuroimmunol. 2014;274:86\u201395.","journal-title":"J Neuroimmunol"},{"key":"1723_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bbi.2016.07.148","volume":"58","author":"A Swanson","year":"2016","unstructured":"Swanson A, Willette AA. Alzheimer\u2019s disease neuroimaging initiative. Neuronal pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer\u2019s disease spectrum. Brain Behav Immun. 2016;58:201\u20138.","journal-title":"Brain Behav Immun"},{"key":"1723_CR45","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3233\/JAD-150897","volume":"50","author":"KE Melah","year":"2016","unstructured":"Melah KE, Lu SY, Hoscheidt SM, Alexander AL, Adluru N, Destiche DJ, Carlsson CM, Zetterberg H, Blennow K, Okonkwo OC, Gleason CE, Dowling NM, Bratzke LC, Rowley HA, Sager MA, Asthana S, Johnson SC, Bendlin BB. Cerebrospinal fluid markers of Alzheimer\u2019s disease pathology and microglial activation are associated with altered white matter microstructure in asymptomatic adults at risk for Alzheimer\u2019s disease. J Alzheimers Dis. 2016;50:873\u201386.","journal-title":"J Alzheimers Dis"},{"key":"1723_CR46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P. Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement. 2016;12:719\u201332.","journal-title":"Alzheimers Dement"},{"key":"1723_CR47","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13046-018-0876-2","volume":"37","author":"B Geng","year":"2018","unstructured":"Geng B, Pan J, Zhao T, Ji J, Zhang C, Che Y, Yang J, Shi H, Li J, Zhou H, Mu X, Xu C, Wang C, Xu Y, Liu Z, Wen H, You Q. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through beta-catenin\/Erk\/Akt signaling in gastric cancer. J Exp Clin Cancer Res. 2018;37:208\u2013018.","journal-title":"J Exp Clin Cancer Res"},{"key":"1723_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000289225","volume":"7","author":"D Uberti","year":"2010","unstructured":"Uberti D, Cenini G, Bonini SA, Barcikowska M, Styczynska M, Szybinska A, Memo M. Increased CD44 gene expression in lymphocytes derived from Alzheimer disease patients. Neurodegener Dis. 2010;7:143\u20137.","journal-title":"Neurodegener Dis"},{"key":"1723_CR49","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ajpath.2011.10.027","volume":"180","author":"SE Perez","year":"2012","unstructured":"Perez SE, Getova DP, He B, Counts SE, Geula C, Desire L, Coutadeur S, Peillon H, Ginsberg SD, Mufson EJ. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer\u2019s disease. Am J Pathol. 2012;180:526\u201340.","journal-title":"Am J Pathol"},{"key":"1723_CR50","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2174\/156720512801322591","volume":"9","author":"FA Schmitt","year":"2012","unstructured":"Schmitt FA, Nelson PT, Abner E, Scheff S, Jicha GA, Smith C, Cooper G, Mendiondo M, Danner DD, Van Eldik LJ, Caban-Holt A, Lovell MA, Kryscio RJ. University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res. 2012;9:724\u201333.","journal-title":"Curr Alzheimer Res"},{"key":"1723_CR51","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00005072-199904000-00008","volume":"58","author":"DG Davis","year":"1999","unstructured":"Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol. 1999;58:376\u201388.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1723_CR52","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1212\/01.WNL.0000152982.47274.9E","volume":"64","author":"DA Bennett","year":"2005","unstructured":"Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005;64:834\u201341.","journal-title":"Neurology"},{"key":"1723_CR53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1006\/exnr.1999.7086","volume":"158","author":"EJ Mufson","year":"1999","unstructured":"Mufson EJ, Chen EY, Cochran EJ, Beckett LA, Bennett DA, Kordower JH. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999;158:469\u201390.","journal-title":"Exp Neurol"},{"key":"1723_CR54","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology. 1984;34:939\u201344.","journal-title":"Neurology."},{"key":"1723_CR55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneur.1989.00520400033016","volume":"46","author":"EH Rubin","year":"1989","unstructured":"Rubin EH, Morris JC, Grant EA, Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch Neurol. 1989;46:379\u201382.","journal-title":"Arch Neurol"},{"key":"1723_CR56","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1001\/jama.1995.03520400044042","volume":"273","author":"RC Petersen","year":"1995","unstructured":"Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT. Apolipoprotein E status as a predictor of the development of Alzheimer\u2019s disease in memory-impaired individuals. JAMA. 1995;273:1274\u20138.","journal-title":"JAMA"},{"key":"1723_CR57","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1001\/archneur.1995.00540300086018","volume":"52","author":"EM Ebly","year":"1995","unstructured":"Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol. 1995;52:612\u20139.","journal-title":"Arch Neurol"},{"key":"1723_CR58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1532-5415.1997.tb00947.x","volume":"45","author":"DP Devanand","year":"1997","unstructured":"Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc. 1997;45:321\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"1723_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/00207459109150691","volume":"57","author":"M Albert","year":"1991","unstructured":"Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer\u2019s disease. Int J Neurosci. 1991;57:167\u201378.","journal-title":"Int J Neurosci"},{"key":"1723_CR60","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.41.7.1006","volume":"41","author":"C Flicker","year":"1991","unstructured":"Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41:1006\u20139.","journal-title":"Neurology"},{"key":"1723_CR61","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/NEN.0b013e318272caab","volume":"71","author":"EJ Mufson","year":"2012","unstructured":"Mufson EJ, He B, Nadeem M, Perez SE, Counts SE, Leurgans S, Fritz J, Lah J, Ginsberg SD, Wuu J, Scheff SW. Hippocampal proNGF signaling pathways and beta-amyloid levels in mild cognitive impairment and Alzheimer disease. JNeuropathol Exp Neurol. 2012;71:1018\u201329.","journal-title":"JNeuropathol Exp Neurol"},{"key":"1723_CR62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"1723_CR63","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/00005072-199911000-00004","volume":"58","author":"KL Newell","year":"1999","unstructured":"Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol. 1999;58:1147\u201355.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1723_CR64","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/S0197-4580(97)00058-4","volume":"18","author":"SS Mirra","year":"1997","unstructured":"Mirra SS. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease: a commentary. Neurobiol Aging. 1997;18:S91\u20134.","journal-title":"Neurobiol Aging"},{"key":"1723_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT, National Institute on Aging, Alzheimer\u2019s Association. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 2012;123:1\u201311.","journal-title":"Acta Neuropathol"},{"key":"1723_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-011-0884-1","volume":"123","author":"EJ Mufson","year":"2012","unstructured":"Mufson EJ, Binder L, Counts SE, DeKosky ST, de Toledo-Morrell L, Ginsberg SD, Ikonomovic MD, Perez SE, Scheff SW. Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol. 2012;123:13\u201330.","journal-title":"Acta Neuropathol"},{"key":"1723_CR67","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66:1837\u201344.","journal-title":"Neurology"},{"key":"1723_CR68","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.61.3.378","volume":"61","author":"DA Bennett","year":"2004","unstructured":"Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol. 2004;61:378\u201384.","journal-title":"Arch Neurol"},{"key":"1723_CR69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neurobiolaging.2016.03.003","volume":"43","author":"EJ Mufson","year":"2016","unstructured":"Mufson EJ, Malek-Ahmadi M, Snyder N, Ausdemore J, Chen K, Perez SE. Braak stage and trajectory of cognitive decline in noncognitively impaired elders. Neurobiol Aging. 2016;43:101\u201310.","journal-title":"Neurobiol Aging"},{"key":"1723_CR70","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1177\/002215540004801206","volume":"48","author":"TW Mitchell","year":"2000","unstructured":"Mitchell TW, Nissanov J, Han LY, Mufson EJ, Schneider JA, Cochran EJ, Bennett DA, Lee VM, Trojanowski JQ, Arnold SE. Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment. J Histochem Cytochem. 2000;48:1627\u201338.","journal-title":"J Histochem Cytochem"},{"key":"1723_CR71","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.biopsych.2013.12.016","volume":"77","author":"SE Perez","year":"2015","unstructured":"Perez SE, He B, Nadeem M, Wuu J, Scheff SW, Abrahamson EE, Ikonomovic MD, Mufson EJ. Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer\u2019s disease. Biol Psychiatry. 2015;77:693\u2013703.","journal-title":"Biol Psychiatry"},{"key":"1723_CR72","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12974-017-0893-7","volume":"14","author":"M Querol-Vilaseca","year":"2017","unstructured":"Querol-Vilaseca M, Colom-Cadena M, Pegueroles J, San Martin-Paniello C, Clarimon J, Belbin O, Fortea J, Lleo A. YKL-40 (chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer\u2019s disease and other tauopathies. J Neuroinflammation. 2017;14:118\u2013017.","journal-title":"J Neuroinflammation"},{"key":"1723_CR73","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2015.10.012","volume":"37","author":"EJ Mufson","year":"2016","unstructured":"Mufson EJ, Malek-Ahmadi M, Perez SE, Chen K. Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment. Neurobiol Aging. 2016;37:147\u201353.","journal-title":"Neurobiol Aging"},{"key":"1723_CR74","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jns.2016.08.029","volume":"369","author":"C Sanfilippo","year":"2016","unstructured":"Sanfilippo C, Malaguarnera L, Di Rosa M. Chitinase expression in Alzheimer\u2019s disease and non-demented brains regions. J Neurol Sci. 2016;369:242\u20139.","journal-title":"J Neurol Sci"},{"key":"1723_CR75","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2174\/1570159X15666170208124324","volume":"15","author":"P Muszynski","year":"2017","unstructured":"Muszynski P, Groblewska M, Kulczynska-Przybik A, Kulakowska A, Mroczko B. YKL-40 as a potential biomarker and a possible target in therapeutic strategies of Alzheimer\u2019s disease. Curr Neuropharmacol. 2017;15:906\u201317.","journal-title":"Curr Neuropharmacol"},{"key":"1723_CR76","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3233\/JAD-170220","volume":"59","author":"P Muszynski","year":"2017","unstructured":"Muszynski P, Kulczynska-Przybik A, Borawska R, Litman-Zawadzka A, Slowik A, Klimkowicz-Mrowiec A, Pera J, Dziedzic T, Mroczko B. The relationship between markers of inflammation and degeneration in the central nervous system and the blood-brain barrier impairment in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;59:903\u201312.","journal-title":"J Alzheimers Dis"},{"key":"1723_CR77","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-017-0226-4","volume":"12","author":"F Llorens","year":"2017","unstructured":"Llorens F, Thune K, Tahir W, Kanata E, Diaz-Lucena D, Xanthopoulos K, Kovatsi E, Pleschka C, Garcia-Esparcia P, Schmitz M, Ozbay D, Correia S, Correia A, Milosevic I, Andreoletti O, Fernandez-Borges N, Vorberg IM, Glatzel M, Sklaviadis T, Torres JM, Krasemann S, Sanchez-Valle R, Ferrer I, Zerr I. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. Mol Neurodegener. 2017;12:83\u2013017.","journal-title":"Mol Neurodegener"},{"key":"1723_CR78","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1523\/JNEUROSCI.4037-13.2014","volume":"34","author":"AA Sosunov","year":"2014","unstructured":"Sosunov AA, Wu X, Tsankova NM, Guilfoyle E, McKhann GM, Goldman JE. Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain. J Neurosci. 2014;34:2285\u201398.","journal-title":"J Neurosci"},{"key":"1723_CR79","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0006-8993(93)91160-T","volume":"632","author":"H Akiyama","year":"1993","unstructured":"Akiyama H, Tooyama I, Kawamata T, Ikeda K, McGeer PL. Morphological diversities of CD44 positive astrocytes in the cerebral cortex of normal subjects and patients with Alzheimer\u2019s disease. Brain Res. 1993;632:249\u201359.","journal-title":"Brain Res"},{"key":"1723_CR80","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1074\/jbc.M116.764985","volume":"292","author":"AA Kognole","year":"2017","unstructured":"Kognole AA, Payne CM. Inhibition of mammalian glycoprotein YKL-40: identification of the physiological ligand. J Biol Chem. 2017;292:2624\u201336.","journal-title":"J Biol Chem"},{"key":"1723_CR81","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","volume":"15","author":"BP Toole","year":"2009","unstructured":"Toole BP. Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin Cancer Res. 2009;15:7462\u20138.","journal-title":"Clin Cancer Res"},{"key":"1723_CR82","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/cne.23965","volume":"524","author":"S Dauth","year":"2016","unstructured":"Dauth S, Grevesse T, Pantazopoulos H, Campbell PH, Maoz BM, Berretta S, Parker KK. Extracellular matrix protein expression is brain region dependent. J Comp Neurol. 2016;524:1309\u201336.","journal-title":"J Comp Neurol"},{"key":"1723_CR83","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","volume":"24","author":"WL Klein","year":"2001","unstructured":"Klein WL, Krafft GA, Finch CE. Targeting small Abeta oligomers: the solution to an Alzheimer\u2019s disease conundrum? Trends Neurosci. 2001;24:219\u201324.","journal-title":"Trends Neurosci"},{"key":"1723_CR84","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","volume":"96","author":"AY Hsia","year":"1999","unstructured":"Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L. Plaque-independent disruption of neural circuits in Alzheimer\u2019s disease mouse models. Proc Natl Acad Sci U S A. 1999;96:3228\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1723_CR85","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998;95:6448\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1723_CR86","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1523\/JNEUROSCI.2768-16.2016","volume":"37","author":"SJ Lee","year":"2017","unstructured":"Lee SJ, Wei M, Zhang C, Maxeiner S, Pak C, Calado Botelho S, Trotter J, Sterky FH, Sudhof TC. Presynaptic neuronal pentraxin receptor organizes excitatory and inhibitory synapses. J Neurosci. 2017;37:1062\u201380.","journal-title":"J Neurosci"},{"key":"1723_CR87","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0014-5793(94)00829-9","volume":"351","author":"S Khatoon","year":"1994","unstructured":"Khatoon S, Grundke-Iqbal I, Iqbal K. Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett. 1994;351:80\u20134.","journal-title":"FEBS Lett"},{"key":"1723_CR88","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jalz.2019.01.004","volume":"15","author":"I Bos","year":"2019","unstructured":"Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleo A, Johannsen P, Freund-Levi Y, Frolich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer\u2019s disease spectrum. Alzheimers Dement. 2019;15:644\u201354.","journal-title":"Alzheimers Dement"},{"key":"1723_CR89","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","volume":"73","author":"H Zetterberg","year":"2016","unstructured":"Zetterberg H, Skillback T, Mattsson N, Trojanowski JQ, Portelius E, Shaw LM, Weiner MW, Blennow K. Alzheimer\u2019s disease neuroimaging initiative. Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression. JAMA Neurol. 2016;73:60\u20137.","journal-title":"JAMA Neurol"},{"key":"1723_CR90","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3389\/fimmu.2018.00764","volume":"9","author":"KBM Reid","year":"2018","unstructured":"Reid KBM. Complement component C1q: historical perspective of a functionally versatile, and structurally unusual, serum protein. Front Immunol. 2018;9:764.","journal-title":"Front Immunol"},{"key":"1723_CR91","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.25172","volume":"83","author":"EJ Goetzl","year":"2018","unstructured":"Goetzl EJ, Schwartz JB, Abner EL, Jicha GA, Kapogiannis D. High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann Neurol. 2018;83:544\u201352.","journal-title":"Ann Neurol"},{"key":"1723_CR92","doi-asserted-by":"publisher","first-page":"2530414","DOI":"10.1155\/2018\/2530414","volume":"2018","author":"C Luchena","year":"2018","unstructured":"Luchena C, Zuazo-Ibarra J, Alberdi E, Matute C, Capetillo-Zarate E. Contribution of neurons and glial cells to complement-mediated synapse removal during development, aging and in Alzheimer\u2019s disease. Mediators Inflamm. 2018;2018:2530414.","journal-title":"Mediators Inflamm"},{"key":"1723_CR93","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-immunol-032713-120154","volume":"32","author":"VM Holers","year":"2014","unstructured":"Holers VM. Complement and its receptors: new insights into human disease. Annu Rev Immunol. 2014;32:433\u201359.","journal-title":"Annu Rev Immunol"},{"key":"1723_CR94","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, Lemere CA, Selkoe DJ, Stevens B. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science."},{"key":"1723_CR95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12640-016-9606-8","volume":"30","author":"AD Kraft","year":"2016","unstructured":"Kraft AD, McPherson CA, Harry GJ. Association between microglia, inflammatory factors, and complement with loss of hippocampal mossy fiber synapses induced by Trimethyltin. Neurotox Res. 2016;30:53\u201366.","journal-title":"Neurotox Res"},{"key":"1723_CR96","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1586\/14737175.8.12.1879","volume":"8","author":"CA Gold","year":"2008","unstructured":"Gold CA, Budson AE. Memory loss in Alzheimer\u2019s disease: implications for development of therapeutics. Expert Rev Neurother. 2008;8:1879\u201391.","journal-title":"Expert Rev Neurother"},{"key":"1723_CR97","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.nicl.2014.02.001","volume":"4","author":"AM Racine","year":"2014","unstructured":"Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, Cleary CA, Birdsill A, Hillmer AT, Murali D, Barnhart TE, Gallagher CL, Carlsson CM, Rowley HA, Dowling NM, Asthana S, Sager MA, Bendlin BB, Johnson SC. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer\u2019s disease: a multimodal imaging investigation. Neuroimage Clin. 2014;4:604\u201314.","journal-title":"Neuroimage Clin"},{"key":"1723_CR98","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1016\/j.neurobiolaging.2014.05.027","volume":"35","author":"JL Molinuevo","year":"2014","unstructured":"Molinuevo JL, Ripolles P, Simo M, Llado A, Olives J, Balasa M, Antonell A, Rodriguez-Fornells A, Rami L. White matter changes in preclinical Alzheimer\u2019s disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid beta protein 42 levels. Neurobiol Aging. 2014;35:2671\u201380.","journal-title":"Neurobiol Aging"},{"key":"1723_CR99","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/mp.2010.90","volume":"16","author":"V Heise","year":"2011","unstructured":"Heise V, Filippini N, Ebmeier KP, Mackay CE. The APOE varepsilon4 allele modulates brain white matter integrity in healthy adults. Mol Psychiatry. 2011;16:908\u201316.","journal-title":"Mol Psychiatry"},{"key":"1723_CR100","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1038\/s41598-019-41363-2","volume":"9","author":"F Ji","year":"2019","unstructured":"Ji F, Pasternak O, Ng KK, Chong JSX, Liu S, Zhang L, Shim HY, Loke YM, Tan BY, Venketasubramanian N, Chen CL, Zhou JH. White matter microstructural abnormalities and default network degeneration are associated with early memory deficit in Alzheimer\u2019s disease continuum. Sci Rep. 2019;9:4749\u2013019.","journal-title":"Sci Rep"},{"key":"1723_CR101","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0014-4827(03)00069-7","volume":"287","author":"KC Nishikawa","year":"2003","unstructured":"Nishikawa KC, Millis AJ. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res. 2003;287:79\u201387.","journal-title":"Exp Cell Res"},{"key":"1723_CR102","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jocn.2019.03.035","volume":"64","author":"Y Shi","year":"2019","unstructured":"Shi Y, Song Y, Liu P, Li P. YKL-40 can promote angiogenesis in sporadic cerebral cavernous malformation (CCM). J Clin Neurosci. 2019;64:220\u20136.","journal-title":"J Clin Neurosci"},{"key":"1723_CR103","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1042\/CS20160604","volume":"131","author":"GA Rosenberg","year":"2017","unstructured":"Rosenberg GA. Extracellular matrix inflammation in vascular cognitive impairment and dementia. Clin Sci (Lond). 2017;131:425\u201337.","journal-title":"Clin Sci (Lond)"},{"key":"1723_CR104","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000008242","volume":"44","author":"A Wallin","year":"2000","unstructured":"Wallin A, Sjogren M, Edman A, Blennow K, Regland B. Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia. Eur Neurol. 2000;44:229\u201335.","journal-title":"Eur Neurol"},{"key":"1723_CR105","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fncel.2014.00362","volume":"8","author":"AC da Fonseca","year":"2014","unstructured":"da Fonseca AC, Matias D, Garcia C, Amaral R, Geraldo LH, Freitas C, Lima FR. The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell Neurosci. 2014;8:362.","journal-title":"Front Cell Neurosci"},{"key":"1723_CR106","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jalz.2019.01.015","volume":"15","author":"A Lleo","year":"2019","unstructured":"Lleo A, Alcolea D, Martinez-Lage P, Scheltens P, Parnetti L, Poirier J, Simonsen AH, Verbeek MM, Rosa-Neto P, Slot RER, Tainta M, Izaguirre A, Reijs BLR, Farotti L, Tsolaki M, Vandenbergue R, Freund-Levi Y, Verhey FRJ, Clarimon J, Fortea J, Frolich L, Santana I, Molinuevo JL, Lehmann S, Visser PJ, Teunissen CE, Zetterberg H, Blennow K. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer\u2019s disease continuum in the BIOMARKAPD study. Alzheimers Dement. 2019;15:742\u201353.","journal-title":"Alzheimers Dement"},{"key":"1723_CR107","doi-asserted-by":"crossref","unstructured":"Smirnov D, Salmon DP, Edland SD, Vanmechelen E, Vanderstichele HM, De Wit N, Vanbrabant J, Jacobs D, Xu D, Xiao M-F, Worley PF, Galasko DR. CSF Biomarkers of amyloid, tau and synaptic damage (Neurogranin, SNAP25) and interneuron-dependent synaptic homeostasis (NPTX2) in CSF As predictors of cognitive progression in MCI and AD. ISTAART Alzheimers Dement. 2019. AAIC Abstract ID 33762.","DOI":"10.1016\/j.jalz.2019.06.4556"},{"key":"1723_CR108","doi-asserted-by":"crossref","unstructured":"Galasko DR, Smirnov D, Salmon DP, De Wit N, Jacobs D, Vanbrabant J, Vanmechelen E, Vanderstichele HM, Xu D, Xiao M-F, Worley PF. CSF Biomarkers of Synaptic Damage (Neurogranin, SNAP25) and interneuron-dependent synaptic homeostasis (NPTX2) improve diagnostic classification of MCI and AD and correlate with cognition. ISTAART Alzheimers Dement. 2019. AAIC Abstract ID 33463.","DOI":"10.1016\/j.jalz.2019.06.4859"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-1723-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-020-1723-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-1723-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:28:09Z","timestamp":1695774489000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-020-1723-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,17]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1723"],"URL":"https:\/\/doi.org\/10.1186\/s12974-020-1723-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,17]]},"assertion":[{"value":"21 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Human Research Committees of Rush University Medical Center approved this study, and informed consent for research and autopsy was obtained from the Rush Religious Orders Study participants, families, or guardians.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}